The purpose of this study is to demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDETINBACK Sweet Flower.

Inclusion criteria:

• Phototype Skin II and III;
• Integral skin test in the region;
• Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion criteria:

• Lactation or gestation
• Use of Antiinflammatory and/or immunosuppression drugs 15 days before the selection;
• Diseases which can cause immunity decrease, such as HIV, diabetes;
• Use of drug photosensitizer;
• History of sensitivity or irritation for topic products;
• Active cutaneous disease which can change the study results;
• History of photodermatosis active;
• Family or personal antecedent of cutaneous photoinduced neoplasias;
• Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and queratoses actinium;
• Intense solar exposure in the study area;
• Use of new drugs or cosmetics during the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.